Scarica l'app Stockscreener
283.45
1.45%
-4.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$287.53
Aprire:
$285
Volume 24 ore:
1.19M
Relative Volume:
1.98
Capitalizzazione di mercato:
$16.87B
Reddito:
$2.91B
Utile/perdita netta:
$622.64M
Rapporto P/E:
27.05
EPS:
10.48
Flusso di cassa netto:
$620.14M
1 W Prestazione:
-6.84%
1M Prestazione:
-17.30%
6M Prestazione:
-31.52%
1 anno Prestazione:
-6.39%
Intervallo 1D:
$279.62
$285.88
Intervallo di 1 settimana:
$279.62
$309.75
Portata 52W:
$279.62
$423.56
Waters Corp Stock (WAT) Company Profile
Nome
Waters Corp
Settore
Industria
Telefono
(508) 478-2000
Indirizzo
34 MAPLE ST, MILFORD, MA
Confronta WAT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
283.43 | 18.10B | 2.91B | 622.64M | 620.14M | 10.48 |
|
TMO
Thermo Fisher Scientific Inc
|
407.60 | 160.56B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.28 | 141.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
519.59 | 42.74B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.00 | 34.11B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
159.34 | 27.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-31 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-08-01 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2023-11-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-05-18 | Iniziato | Barclays | Overweight |
| 2022-05-17 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Aggiornamento | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Aggiornamento | Citigroup | Sell → Neutral |
| 2020-12-02 | Iniziato | Goldman | Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Downgrade | Needham | Hold → Underperform |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Sell |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-09 | Downgrade | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Iniziato | Wolfe Research | Underperform |
| 2019-01-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Iniziato | Needham | Hold |
| 2018-12-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Downgrade | Goldman | Neutral → Sell |
| 2018-10-11 | Aggiornamento | Cleveland Research | Sell → Neutral |
Mostra tutto
Waters Corp Borsa (WAT) Ultime notizie
Inside the deal: Waters CEO Udit Batra defends $17.5B merger with BD unit - The Business Journals
Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - MSN
Waters Corp (WAT) Shares Decline 3.39% Amid Analyst Forecast - AInvest
Waters downgraded at Wells Fargo after Becton, Dickinson deal - MSN
Waters to buy Becton unit in a $17.5 billion deal amid tariff pressures - MSN
Under CEO Udit Batra's Leadership, Waters to Merge with BD Unit in $17.5 Billion Deal to Create Life Sciences Powerhouse - INDIA New England News
What analysts say about Waters Corporation stockMarket-beating performance - jammulinksnews.com
Waters Corp. stock underperforms Friday when compared to competitors - MarketWatch
Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know - Yahoo Finance
Taxation With Representation: Wachtell, Slaughter And May - Law360
Is Waters Corporation a good long term investmentFree Daily Trading Room Entry - jammulinksnews.com
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom - Investing.com
Becton to merge unit with Waters in $17.5 billion deal - MSN
Waters Corp Is Taking On Thermo Fisher & Danaher With This $17.5 Billion Becton Dickinson Acquisition! - Smartkarma
What to Expect From Waters Corporation's Next Quarterly Earnings Report - MSN
Waters Corp. stock underperforms Tuesday when compared to competitors - MSN
symbol__ Stock Quote Price and Forecast - CNN
Becton to merge biosciences and diagnostics arm with Waters in $17.5 billion deal - MSN
Waters to merge with Becton's biosciences and diagnostics arm in $17.5 billion deal - MSN
Waters (WAT) Stock Target Price Lowered by Baird Analyst | WAT S - GuruFocus
Waters (WAT) Price Target Reduced by Baird Analyst | WAT Stock N - GuruFocus
Waters Shares Dip After $17.5 Billion Merger Announcement with BD Biosciences Unit - MSN
Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks - MSN
Waters stock downgraded at Wells Fargo on BD deal (WAT:NYSE) - Seeking Alpha
Waters Corporation stock hits 52-week low at 297.03 USD By Investing.com - Investing.com Canada
UBS reiterates Neutral rating on Waters stock, maintains $360 price target - Investing.com Nigeria
UBS reiterates Neutral rating on Waters stock, maintains $360 price target By Investing.com - Investing.com South Africa
Waters deal adds variables to ‘clean’ story, says Jefferies - Yahoo Finance
Waters stock rating reiterated at Hold by Stifel after BDX asset acquisition - Investing.com Nigeria
BD Partners With Waters to Build High-Volume Diagnostics Leader - Yahoo Finance
Street View: Waters’ $17.5 billion merger draws both optimism and caution - TradingView
Waters stock price target lowered to $330 from $375 at BofA Securities - Investing.com Nigeria
An $18 bln health deal faces risks outside the lab - Reuters
Waters stock price target lowered to $330 from $375 at BofA Securities By Investing.com - Investing.com South Africa
Waters Corp. & BD to become life science and diagnostics leader - ROI-NJ
Five things: Waters, lab leases, Legacy FC, classic cars and an ocean view - The Business Journals
Waters Corporation: A Path to Diversification via the Becton Diagnostics Merger - AInvest
Waters: Becoming A Diversified Giant Following The Becton Diagnostics Merger - Seeking Alpha
Waters' $17.5B BD Deal: A Bold Bet on Life Sciences Resilience Amid Tariff Storms - AInvest
Stock Movers: Waters, Autodesk, Palantir - Bloomberg
BD’s biosciences & diagnostics unit in $17.5B merger with Waters - BioWorld MedTech
Waters to buy Becton unit in a $17.5 billion deal amid tariff pressures By Reuters - Investing.com
Waters’ Purchase Of BD Biosciences & Dx Brings Growth Potential Alongside Trade-Offs - insights.citeline.com
Waters to combine with BD's biosciences unit, creating a $40B life science and diagnostics heavyweight - R&D World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGRM, WAT, VBTX on Behalf of Shareholders - GlobeNewswire Inc.
Becton Dickinson Finds a Partner for Its Biosciences and Diagnostics Business in Waters - Morningstar
Waters to Merge with BD's Life Science and Diagnostics Business - Morningstar
Milford’s Waters Corp. strikes $17.5 billion deal to merge with BD’s diagnostics unit - The Boston Globe
Waters to buy Becton Dickinson unit in a $17.5 billion deal amid tariff pressures - CNBC
Waters, BD Unite in $17.5B Diagnostics Deal - USA Herald
Waters to buy multinational firm’s bioscience division for $17.5B - Worcester Business Journal
Waters Corp Azioni (WAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.25%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):